The use of intravascular ultrasound imaging to improve use of inferior vena cava filters in a high-risk bariatric population  by Kardys, Clark M. et al.
From the Society for Clinical Vascular Surgery
The use of intravascular ultrasound imaging
to improve use of inferior vena cava filters
in a high-risk bariatric population
Clark M. Kardys, MD, Michael C. Stoner, MD, Mark L. Manwaring, MD, William M. Bogey, MD,
Frank M. Parker, DO, and Steve Powell, MD, Greenville, North Carolina
Objective: Pulmonary embolism is the leading cause of death after gastric bypass procedures for obesity, approximating
0.5% to 4%. All bariatric patients, but especially the super-obese, which have a body mass index (BMI) >50 kg/m2, are
at significant risk for postoperative venous thromboembolism (VTE). Visualization and weight limitations of fluoroscopy
tables exclude most bariatric and all super-obese patients from inferior vena cava (IVC) filter placement using
fluoroscopy. Intravascular ultrasound (IVUS)-guided IVC filter placement is the only modality that allows these
high-risk patients to have an IVC filter placed.
Methods: Hospital and outpatient records of the 494 patients who underwent gastric bypass procedures from January 1,
2004, to May 31, 2006, were reviewed. All patients who had concurrent IVC filter placement with the use of IVUS
guidance were selected. Comorbidities, outcomes, and complications were recorded.
Results: We identified 27 patients with mean BMI of 70  3 kg/m2; of these, 25 were super-obese (BMI >50 kg/m2).
Procedures included five laparoscopic and 22 open gastric bypass operations. All patients underwent concurrent IVC
filter placement using IVUS guidance. In addition to super-obesity, indications for IVC filter placement included history
of VTE (n  4), known hypercoagulable state (n  2), and profound immobility (n  21). Mean follow up was 293 
40 days. Technical success rate was 96.3%. There were no catheter site complications. In one surviving patient, a nonfatal
pulmonary embolism was detected by computed tomography 2 months postoperatively. Two patients died, and autopsy
excluded VTE as the cause of death in both.
Conclusion: This study suggests efficacy of IVUS-guided IVC filter placement in preventing mortality from pulmonary
embolism in high-risk bariatric patients, including the super-obese. IVUS-guided IVC filter placement can be safely
performed with an excellent success rate in all bariatric patients, including the super-obese, who otherwise would not be
candidates for IVC filter placement due to the limitations imposed by their large body habitus. ( J Vasc Surg 2007;46:
1248-52.)Postoperative pulmonary embolism (PE) is the leading
cause of death after gastric bypass procedures for obesity, with
an incidence of 0.5% to 4%.1-7 Super-obese patients, defined
as having a body mass index (BMI)  50 kg/m2, are at
increased risk for venous thromboembolism (VTE) due to
multiple physical and physiologic factors, with PE rates as high
as 28%.1,25,6,8-12 The mortality from PE in super-obese pa-
tients is reported to be 27% to 75%.4,6 Current techniques for
deep venous thrombosis (DVT) prophylaxis include sequen-
tial compression devices, early ambulation, and medical pro-
phylaxis with heparin or low-molecular-weight heparin
(LMWH).4,5,13-15 The success of these protocols in PE pre-
vention continues to be mixed.4 Inferior vena cava (IVC)
filters have previously been shown to decrease the incidence of
and mortality from PE in bariatric surgery patients.1,4,6,9,13-21
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1248IVC filters are recommended for those patients with
super-obesity, decreased mobility, venous insufficiency, previ-
ous thromboembolic event, or hypercoagulability. As BMI
increases, visualization of the vena cava becomes more difficult
fluoroscopically and eventually becomes suboptimal. Some
super-obese patients may be excluded from IVC filter place-
ment with fluoroscopy due to table weight limits and inade-
quate fluoroscopic penetration. Transabdominal ultrasound
imaging has been used for IVC filter placement but is limited
in all obese patients by increased abdominal girth and overly-
ing bowel gas.22-24 Intravascular ultrasound (IVUS) imaging
offers a technique for IVC filter placement for bariatric pa-
tients, including those who are super-obese, which is unaf-
fected by body habitus.3,9,17,22-29 This study examined a
contemporary series of IVUS-guided IVCfilter placement in a
high-risk population of bariatric patients. This study was ap-
proved and performed in accordance with the regulations of
the Institutional Review Board of East Carolina University.
METHODS
A retrospective review of all bariatric patients who
underwent IVUS-guided IVC filter placement at the time
of their gastric bypass procedure was performed. Recorded
data included history of DVT, PE, hypercoagulable disor-
der, arthritis, pain in weight bearing joints, chronic ob-
structive pulmonary disease, asthma, obstructive sleep ap-
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BMI, complications, postoperative PE or DVT, and time of
follow-up. Venous insufficiency was defined by ankle
edema without associated foot edema for a CEAP clinical
score of at least 3.30 Sleep apnea was defined by a sleep
study with a positive result. Results were reported as mean
and standard error. History and physical exams were per-
formed in the bariatric clinic and in the vascular surgery
clinic within the same university practice.
Super-obese patients and patients with a history of
venous insufficiency, hypercoagulable disorder, profound
immobility, and a history of VTE were considered for IVC
filter placement. There was no specific BMI threshold at
which all bariatric patients had IVC filter placement; how-
ever, those with BMI 50 kg/m2 were considered for filter
placement on the basis of BMI alone.
Adjunctive DVT prophylaxis in this study included
sequential compression devices or foot pumps placed be-
fore operation and 5000 U of heparin given subcutane-
ously in preoperative holding. Patients ambulated the day
of surgery if they were not in the intensive care unit. They
received 5000 U of heparin three times daily and continued
to have sequential compression devices in place while in
bed. Patients with BMI 60 kg/m2 were treated with
Enoxaparin (Sanofi-Aventis, Paris, France) for 2 weeks
postoperatively. They were given 40 mg of Enoxaparin
twice a day rather than the standard daily dose of 40 mg.
Follow-up abdominal radiographs were performed the
day of the operation to confirm filter placement. Patients
were followed up in the bariatric surgery clinic at 2 weeks;
2, 4, 6, and 9 months, 1 year, and then annually. Insertion
site exams and complaints related to filter thrombosis or
VTE were recorded. Any filter-related problems or com-
plaints were referred to the vascular surgeons within the
same university practice.
Technique of filter insertion. Each patient was su-
pine under general anesthesia. Both groins were prepared.
The femoral vein, most frequently the right, was cannu-
lated with an 18-gauge needle. The Seldinger technique
was used to place an 8F sheath. A second percutaneous
access was obtained immediately cephalad to the first, and a
12F sheath was placed.
Imaging was performed with a Galaxy 1 (Boston Scientific
Corp, Natick, Mass). The 8F, 12.5-Mhz IVUS probe was
passed through the femoral vein cephalad to the IVC and to
the right atrium. The catheter was pulled back, visualizing in
sequence the hepatic veins, the right renal artery, renal veins,
and finally the iliac confluence before being returned to the
level of the renal veins. The IVC was measured at the level of
the renal veins to ensure its size was between 20 and 28 mm in
greatest diameter. With concurrent IVUS imaging, a stainless
steel over-the-wire Greenfield Vena Cava Filter (Boston Sci-
entific Corp) was inserted through the 12F sheath and placed
so that the filter’s tip rested at or below the middle portion of
the renal veins (Fig 1).
The filter was deployed and IVUS was used to view the
struts of the filter to ensure appropriate strut spacing and
apposition to the vena cava (Fig 2). The sheaths wereremoved and pressure held for 5 minutes. The location of
the filter was verified with a postoperative abdominal radio-
graph.23
RESULTS
From January 2004 to April 2006, 27 patients under-
went IVUS-directed IVC filter placement at the time of
their gastric bypass procedure. Their mean age was 42 
Fig 1. Intravascular ultrasound probe at the renal veins.
Fig 2. Intravascular ultrasound imaging shows that the struts of
the inferior vena cava filter (IVC) are appropriately spaced and in
apposition to the vena cava.1.8 years (range, 20 to 59 years), their mean BMI was 70
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patients were super-obese (BMI 50 kg/m2). Of the two
patients who were not super-obese, one had a history of
DVT and the second had obstructive sleep apnea and
venous insufficiency. All procedures were Roux-en-Y gas-
tric bypass performed by open (n  22) or laparoscopic
technique (n  5). The most common comorbidities and
risk factors were obstructive sleep apnea (n  16), pain in
weight bearing joints (n  12), and lower extremity edema
(n  9; Table II). A postoperative abdominal radiograph
was used to verify filter position in all patients. Filter place-
ment could not be verified owing to inadequate x-ray
penetration in 5 patients (19%).
Patients were followed up regularly in the bariatric
clinic for the first year and then annually indefinitely. Mean
follow up was 293  40 days (median, 213 days). One
patient was lost to follow up after 79 days, 22 patients
remained in follow-up at 3 months, and nine patients
remained in follow-up after 1 year. Two patients (7%) died
postoperatively, 1 on day 8 and 1 on day 15. Autopsy
confirmed that neither death was related to VTE or filter-
related complications. One patient died from bowel necro-
sis and another died from a tracheoinnominate fistula at her
tracheostomy site. One of these two patients had filter
placement in the right iliac vein and did not have an
Table I. Demographic data of the study population
Demographics








SE, Standard error; BMI, body mass index.
Table II. Comorbidities
Comorbidity No. Percentage
History of PE 3 11
History of VTE 4 15
Factory V Leiden 2 7
COPD 1 4
Asthma 4 15
Obstructive sleep apnea 16 52
Venous insufficiency 4 15
Bilateral 4 15
CEAP C3 3 11
CEAP C5 1 4
Lower extremity edema 9 35
Pain in weight-bearing joints 12 44
Arthritis 5 19
BMI 50 kg/m2 25 93
PE, Pulmonary embolism; VTE, venous thromboembolism;COPD, chronic
obstructive pulmonary disease; BMI, body mass index.opportunity for filter repositioning. An upper extremityDVT developed in 1 surviving patient, and a PE developed
in another patient (4%), which was discovered 41 days
postoperatively by spiral computed tomography (CT).
Lower extremity duplex ultrasound imaging did not demon-
strate DVT in this patient (Table III.) No insertion site hema-
toma or infection occurred. There were no arterial injuries
requiring any secondary intervention. No nerve injuries were
noted during follow-up. Symptoms of venous insufficiency
were not significantly improved during follow-up.
DISCUSSION
Several metabolic and mechanical factors contribute to
the hypercoagulable state of the obese patient. High levels
of leptin are frequently seen in these patients. This is
associated with increased C-reactive protein formation,
which has procoagulant and antithrombolytic properties.
Tumor necrosis factor-, serum amyloid A (SAA), plasmin-
ogen activator inhibitor-1 (PAI-1), adipsin (complement
D), adipocyte complement-related protein (Acrp30), and
interleukin 6 are all elevated in obese patients contribute to
inflammation and hypercoagulability.31,32 Obesity has
been shown to increase intra-abdominal pressure. This
increased pressure is transmitted to the femoral venous
system, contributing to obesity-associated venous insuffi-
ciency. These mechanical and physical factors lead to in-
creased incidence of VTE.4,32-34
Super-obesity (BMI50 kg/m2) has been found to be
an independent risk factor for perioperative mortality in
bariatric patients.4,9 Carmody et al4 demonstrated from a
24-year review of more than 3800 bariatric patients that
BMI 50 kg/m2, venous stasis disease, and obesity hypo-
perfusion syndrome were all independent risk factors for
PE. Widespread use of DVT prophylaxis and the increased
frequency of laparoscopic gastric bypass have not decreased
the rate of PE. The inadequacy of non-weight-based regi-
mens of heparin and Enoxaparin may contribute to this
limited success.4 For this reason, study patients were given
40 mg of Enoxaparin twice a day rather than the standard
40 mg daily dose. In the super-obese bariatric population,
there is less consensus about PE prophylaxis compared with
recommendations for the general population. Many rec-
ommendations are based on adaptations of recommenda-
tions for the general populations rather than on trials of
super-obese bariatric patients.5,13-15,35
In one study by Gargiulo et al,6 patients with a BMI
55 kg/m2 undergoing open gastric bypass demonstrated
a tenfold increase in relative risk of PE. PEs were fatal in
75% of those with a BMI 55 kg/m2. By changing their
Table III. Complications
Complication No. Percentage
Insertion site 0 0
Pulmonary embolism 1 4
Deep venous thrombosis 0 0
Filter malposition 1 4practice and placing an IVC filter in all patients with a BMI
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to 0% and their PE related mortality from 1.6% to 0%. In
patients with a BMI 55 kg/m2 who refused an IVC filter,
the incidence of PE was 22.5%, and 56% of those patients
died of heir PEs.6
The mean BMI of 70 kg/m2 in our study is 40%
higher than the previously stated threshold of 50 kg/m2 for
increased risk of PE. It can be assumed that these patients
would be at significantly greater risk for PE than those
populations with a mean BMI of 50 kg/m2. The PE rate
of 4% in our study was on the high end of published PE
rates, which range from 0.5% to 4% across bariatric popu-
lations with no stratification by BMI.5,6,8-12 This is likely
due to bias in our study because we selected patients for
IVC filter placement because they were at high risk. The
one PE that that did occur in our study was nonfatal and
noted to be small on spiral CT. This patient had a BMI of
69 kg/m2 in addition to factor V Leiden mutation. This
patient was not restarted on Warfarin therapy before dis-
charge. At our facility, patients with a history of VTE or
hypercoagulable disorder are now started on Warfarin ther-
apy in addition to Enoxaparin before discharge, with a
therapeutic international normalized ratio target range of 2
to 3.
Several techniques are available for IVC filter place-
ment in the bariatric population. Traditionally, IVC filters
have been placed under fluoroscopic guidance. Fluoros-
copy table weight limits (225 kg at our facility) preclude the
use of the fixed equipment in some super-obese bariatric
patients. When a bariatric patient does not exceed the
fluoroscopy suite’s weight limit, a separate procedure out-
side the operating room adds to the in-hospital time and
resource usage. The radiation dose required for adequate
penetration is also significant for patient and staff. Within
the operating room, portable C-arms may provide subop-
timal visualization for IVC filter placement in the some
super-obese patients. IVC filter placement guided by trans-
abdominal ultrasound imaging is very difficult in bariatric
patients, particularly the super-obese. In contrast, visualiza-
tion using the IVUS-guided technique is unaffected by
body habitus.3,23-26,28,29
With IVUS guidance, IVC filters can be placed through
the femoral or jugular veins. In our study, the femoral vein
was used in all cases. Access to the femoral vein requires
retraction of the pannus, and we find the groin regions of
most bariatric patients are relatively flat and accessible once
the pannus is lifted. Surface ultrasound guidance can be
used for femoral vein cannulation if it cannot be obtained
with a routine puncture but was not used to aid venous
cannulation in any of the patients in this study. Access to
the jugular vein is also difficult because patients frequently
have short thick necks. Maintenance of sterile technique
and organization of the operating room is easier when the
equipment is at the foot of the operating table away from
anesthesiology equipment at the crowded head of the table.
Complications of IVC filters include strut fracture,
migration, caval wall erosion, insertion site thrombosis, risk
of DVT, and postphlebitic syndrome. Postphlebitic syn-drome is a serious but rare complication of IVC filter
placement. Given the exceptionally high mortality of PE in
the super-obese and the limited effectiveness of pharmaco-
logic PE prophylaxis in these patients, we consider that the
benefits of PE prophylaxis from the IVC filter outweigh the
risks in this population.18,20,21 In our series there were no
insertion sight hematomas or infections or clinically appar-
ent filter-related complications. Routine ultrasound sur-
veillance for lower extremity DVT was not performed;
however, no patients returned with symptoms of postphle-
bitic syndrome during the mean follow-up of 293 days.
Another option for PE prophylaxis is placement of
removable IVC filters. These filters offer the opportunity
for removal under fluoroscopy generally 6 months of
placement.17,19,36 Many studies in non-bariatric patients
have noted that most of these filters are never removed. In
some cases this is due to a lack of follow-up. Other factors
leading to failure of removal are inability to collapse the
filter, incorporation of the filter into the vessel wall, wall
erosion, or clot trapped in within the filter.17,36 It is our
view that many of the patients in the bariatric population
would not have lost adequate weight to be eligible for
fluoroscopic removal and would still be susceptible to the
VTE risk factors associated with morbid obesity. Contrary
to this view, there are series reporting successful use of
removable IVC filters.37
As a retrospective review, the study has several inherent
weaknesses. In a prospective study, follow-up ultrasound
imaging of the bilateral lower extremities would have been
performed to rule out insertion site thrombosis or occult
DVT.
Patients received close follow-up by the bariatric sur-
geons within the same university-based surgical practice.
Follow-up by vascular surgeons might have demonstrated
more subtle complications. After the postoperative abdom-
inal radiograph, routine radiographic monitoring for filter
migration was not performed.
This review would have been stronger had the records
of the entirety of the bariatric population been available for
review. This would have allowed for evaluation of relative
risk reduction from filter placement as well as risk stratifi-
cation of PE risks at different BMIs. Future study examin-
ing the entirety of the bariatric population correlating the
improvement in risk factors related to weight loss with VTE
incidence in patients receiving and not receiving IVC filters
would be illustrative.
CONCLUSION
Bariatric patients are at increased risk for postoperative
VTE. Those with a history of hypercoagulability, venous
insufficiency, obesity hypoventilation syndrome, profound
immobility, or super-obesity are at even greater risk. As
BMI increases, IVC filter placement using traditional fluo-
roscopic techniques ceases to be feasible due to patient size.
IVUS-guided IVC filter placement offers the ability to
place an IVC filter at the time of bariatric surgery. Our
study demonstrates the safety and applicability of this pro-
cedure. Complications, although potentially significant, are
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IVUS is a safe and effective technology for IVC filter
placement in the bariatric population, especially in super-
obese patients, who would not be candidates for IVC filter
placement by any other modality.
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